IGI, Laboratories (IG) in Focus: Stock Rises 10.6% – Tale of the Tape

ZacksIGI, Laboratories, Inc. (IG) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $5.10 to $5.81 in the past one-month timeframe.

In the last 30 days, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

IGI, Laboratories currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the med-drugs industry include BioCryst Pharmaceuticals, Inc. (BCRX), Enanta Pharmaceuticals, Inc. (ENTA) and Endo International plc (ENDP). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply